Avanos Medical Past Earnings Performance

Past criteria checks 0/6

Avanos Medical has been growing earnings at an average annual rate of 34.9%, while the Medical Equipment industry saw earnings growing at 8.7% annually. Revenues have been declining at an average rate of 0.3% per year.

Key information

34.9%

Earnings growth rate

35.0%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate-0.3%
Return on equity-0.1%
Net Margin-0.2%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S

Apr 17
Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S

Is Avanos Medical (NYSE:AVNS) A Risky Investment?

Jan 05
Is Avanos Medical (NYSE:AVNS) A Risky Investment?

Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates

Aug 14
Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates

When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

Aug 13
When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

Avanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate Buy

Jul 16

We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease

Jun 05
We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease

Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

May 18
Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing

Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital

May 07
Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital

Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

Mar 02
Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

Avanos Medical Q4 2022 Earnings Preview

Feb 20

Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate

Feb 10
Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate

Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching

Jan 13
Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching

Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance

Nov 02

Avanos: Recent Entry To Hyaluronic Acid Market Sparks Interesting Debate

Sep 12

Avanos Medical Q2 2022 Earnings Preview

Aug 08

When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

May 28
When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?

Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

May 03
Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?

Is There An Opportunity With Avanos Medical, Inc.'s (NYSE:AVNS) 41% Undervaluation?

Feb 10
Is There An Opportunity With Avanos Medical, Inc.'s (NYSE:AVNS) 41% Undervaluation?

Should You Think About Buying Avanos Medical, Inc. (NYSE:AVNS) Now?

Dec 21
Should You Think About Buying Avanos Medical, Inc. (NYSE:AVNS) Now?

An Intrinsic Calculation For Avanos Medical, Inc. (NYSE:AVNS) Suggests It's 33% Undervalued

Nov 04
An Intrinsic Calculation For Avanos Medical, Inc. (NYSE:AVNS) Suggests It's 33% Undervalued

Avanos Medical (NYSE:AVNS) Takes On Some Risk With Its Use Of Debt

Sep 10
Avanos Medical (NYSE:AVNS) Takes On Some Risk With Its Use Of Debt

The Strong Earnings Posted By Avanos Medical (NYSE:AVNS) Are A Good Indication Of The Strength Of The Business

Aug 10
The Strong Earnings Posted By Avanos Medical (NYSE:AVNS) Are A Good Indication Of The Strength Of The Business

Is There Now An Opportunity In Avanos Medical, Inc. (NYSE:AVNS)?

Jun 30
Is There Now An Opportunity In Avanos Medical, Inc. (NYSE:AVNS)?

We Think Avanos Medical (NYSE:AVNS) Is Taking Some Risk With Its Debt

Jun 09
We Think Avanos Medical (NYSE:AVNS) Is Taking Some Risk With Its Debt

Avanos Medical Q1 2021 Earnings Preview

May 06

Revenue & Expenses Breakdown

How Avanos Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSE:AVNS Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 24680-230912
31 Dec 23673-1031813
30 Sep 23682-1133513
30 Jun 23683933614
31 Mar 236841833615
31 Dec 226842233415
30 Sep 226962333215
30 Jun 22708-2333216
31 Mar 227231032617
31 Dec 21587-3125731
30 Sep 21736-5232710
30 Jun 21738233410
31 Mar 21715-383349
31 Dec 20715-2932735
30 Sep 207201435416
30 Jun 20705-1736618
31 Mar 20714-2238419
31 Dec 19698-4637338
30 Sep 19678-4238940
30 Jun 19671-2737641
31 Mar 19660-1735442
31 Dec 18652-832742
30 Sep 18649-131343
30 Jun 18634-1631042
31 Mar 18622-2831841
31 Dec 17612-3232238
30 Sep 17-171-15029035
30 Jun 1776-13031137
31 Mar 17327-11233837
31 Dec 16566-8334638
30 Sep 161,5844442117
30 Jun 161,576-43541816
31 Mar 161,565-43441613
31 Dec 15509-10135028
30 Sep 151,612-44344413
30 Jun 151,6312045811
31 Mar 151,656746014
31 Dec 141,6722744217
30 Sep 141,6646938340
30 Jun 141,67512535440
31 Mar 141,67716833739
31 Dec 131,67815536821

Quality Earnings: AVNS is currently unprofitable.

Growing Profit Margin: AVNS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AVNS is unprofitable, but has reduced losses over the past 5 years at a rate of 34.9% per year.

Accelerating Growth: Unable to compare AVNS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AVNS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.4%).


Return on Equity

High ROE: AVNS has a negative Return on Equity (-0.13%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.